Fred Alger Management, LLC Charles River Laboratories International, Inc. Transaction History

Fred Alger Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $40.7 Million - $46.6 Million	-221,629 Reduced 93.32%	15,872 $3.34 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $45.6 Million - $61.7 Million	237,501 New	237,501 $47.9 Million
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $24,291 - $35,985	-119 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $27,339 - $38,745	-107 Reduced 47.35%	119 $34,000
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $17,569 - $22,434	50 Added 28.41%	226 $85,000
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $7,080 - $8,707	19 Added 12.1%	176 $73,000
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $20,297 - $25,643	69 Added 78.41%	157 $58,000
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $21,970 - $26,354	88 New	88 $26,000

695

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.64B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.